Sutro Biopharma (STRO) Non Operating Income (2017 - 2025)
Sutro Biopharma's (STRO) quarterly Non Operating Income came in at -$8.8 million in Q4 2025, down 82.09% year-on-year from -$49.1 million in Q4 2024, and down 4.73% quarter-over-quarter from -$8.4 million in Q3 2025.
Sutro Biopharma (STRO) Non Operating Income (2017 - 2025) Analysis & Trends
Sutro Biopharma has disclosed Non Operating Income across 4 years of filings, most recently posting -$8.8 million for Q4 2025.
- Non Operating Income for Q4 2025 came in at -$8.8 million, down 82.09% year-over-year; the trailing twelve-month figure through Dec 2025 was -$32.8 million (down 345.74% YoY), and the FY2025 annual result was -$32.8 million, down 345.69% from the prior year.
- Non Operating Income came in at -$8.8 million for Q4 2025 at Sutro Biopharma, down from -$8.4 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $19.1 million in Q3 2024 to a low of -$8.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Sutro Biopharma | 252.04 Mn | 252.04 Mn | - | -8.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.80 Mn |
| Sep 30, 2025 | -8.40 Mn |
| Jun 30, 2025 | -8.17 Mn |
| Mar 31, 2025 | -7.45 Mn |
| Dec 31, 2024 | -4.83 Mn |
| Sep 30, 2024 | 19.13 Mn |
| Jun 30, 2024 | 675,000.00 |
| Mar 31, 2024 | -1.62 Mn |
| Dec 31, 2018 | 1.07 Mn |
| Sep 30, 2018 | -68,000.00 |
| Dec 31, 2017 | 120,000.00 |
| Sep 30, 2017 | -180,000.00 |